Abboud Hesham, Mehanna Raja, Machado Andre, Ahmed Anwar, Gostkowski Michal, Cooper Scott, Itin Ilia, Sweeney Patrick, Pandya Mayur, Kubu Cynthia, Floden Darlene, Ford Paul J, Fernandez Hubert H
Center for Neurological Restoration Neurological Institute Cleveland Clinic Cleveland Ohio USA.
Neurology Department Faculty of Medicine Alexandria University Alexandria Egypt.
Mov Disord Clin Pract. 2014 Oct 10;1(4):336-341. doi: 10.1002/mdc3.12090. eCollection 2014 Dec.
Careful, often cumbersome, screening is a fundamental part of DBS evaluation in Parkinson's disease (PD). It often involves a brain MRI, neuropsychological testing, neurological, surgical, and psychiatric evaluation, and "ON/OFF" motor testing. Given that DBS has now been a standard treatment for advanced PD, with clinicians' improved comfort and confidence in screening and referring patients for DBS, we wondered whether we can now streamline our lengthy evaluation process. We reviewed all PD patients evaluated for DBS at our center between 2006 and 2011 and analyzed the reasons for exclusion and for dropping out despite passing the screening process. A total of 223 PD patients who underwent DBS evaluation had complete charting. Only 131 (58.7%) patients were successfully implanted. Sixty-one (27.3%) patients were excluded after screening because of significant cognitive decline (32.7%), early disease with room for medication adjustment (29.5%), behavioral dysfunction (21.3%), suspected secondary parkinsonism or atypical parkinsonism syndrome (13.1%), PD, but with poor levodopa response (11.4%), unrealistic goals (9.8%), PD with predominant axial symptoms (6.5%), significant comorbidities (6.5%), or abnormal brain imaging (3.2%). In addition, 31 (13.9%) patients were cleared for surgery, but either chose not have it (18 patients), were lost to follow-up (12 patients), or were denied by medical insurance (1 patient). Through careful screening, a significant percentage of surgical candidates continue to be identified as less suitable because of a variety of reasons. This underscores the continued need for a comprehensive, multidisciplinary screening process.
谨慎且通常繁琐的筛查是帕金森病(PD)脑深部电刺激(DBS)评估的基本组成部分。它通常包括脑部磁共振成像(MRI)、神经心理学测试、神经学、外科和精神病学评估,以及“开/关”运动测试。鉴于DBS现已成为晚期PD的标准治疗方法,随着临床医生在筛查和推荐患者接受DBS方面的舒适度和信心有所提高,我们想知道现在是否可以简化我们冗长的评估过程。我们回顾了2006年至2011年期间在我们中心接受DBS评估的所有PD患者,并分析了被排除以及尽管通过筛查过程但仍退出的原因。共有223例接受DBS评估的PD患者有完整的病历记录。只有131例(58.7%)患者成功植入。61例(27.3%)患者在筛查后因严重认知功能下降(32.7%)、疾病早期仍有药物调整空间(29.5%)、行为功能障碍(21.3%)、疑似继发性帕金森综合征或非典型帕金森综合征(13.1%)、PD但左旋多巴反应不佳(11.4%)、目标不切实际(9.8%)、以轴性症状为主的PD(6.5%)、严重合并症(6.5%)或脑部影像学异常(3.2%)而被排除。此外,31例(13.9%)患者手术获批,但要么选择不进行手术(18例患者)、失访(12例患者),要么被医疗保险拒绝(1例患者)。通过仔细筛查,相当一部分手术候选人由于各种原因仍被确定为不太适合。这凸显了持续需要全面、多学科的筛查过程。